Our representatives participated in the 18-month meeting of the StretchBio project, held in Freiburg. The meeting was focused on the design and operation of the functional prototype of the sensor.
With this infographic, we proudly show the key facts we have achieved in recent times in promoting gender equality and women’s rights in the company.
Publications have confirmed the importance of developing safe chemical agents using membrane transporter analysis as a criterion. This is reflected in the field of pesticides, one of the areas in which this analysis has been most widely applied.
The main objective of this project is to develop novel 3D in vitro tools derived from the human liver, relevant to the discovery and preclinical phases of drug development.
Inflammatory reactions of the intestinal tract are the result of a combination of hereditary, genetic and/or environmental factors that have been clustered in the inflammatory bowel disease (IBD). ReadyCell has available CacoReady and CacoGoblet to assay compounds inflammatory properties.
A new drug against malignant cells was found using methods such as High Throughput Screening (HTS) and Caco-2 permeability assay with CacoReady plates.
We want to send you our greetings and best wishes for the holiday season! This year, artists from the art studio of the AMPANS Foundation created a special Christmas card.
The Drug Discovery Summit (DDS) includes high-level national and international speakers, interactive roundtables, knowledge-sharing panel sessions, workshops and networking.
The U.S. company Adari Cell Science met with ReadyCell at the Parc Científic de Barcelona and shared their impressions of the past year.
ReadyCell wants to contribute to the knowledge of science through scientific divulgation and didactics. For this purpose, we have prepared some games with scientific concepts to better understand processes.
ReadyCell SL in the context of the ICEX Next Program, has been supported by ICEX and co-financed by the European FEDER fund. The purpose of this support is to contribute to the international development of the company and its environment.
The presence of the superfamily members of the ATP binding cassette (ABC) transporters is well established as the main cause of multidrug resistance, since they efflux therapeutic compounds from cells and reduce the intracellular drug levels.
Readycell participated in the annual meeting of the StretchBio Project, which was held at the Danmarks Tekniske Universitet (DTU) in Copenhagen.
An investigation led by the researcher Nicoló Milani was published in the prestigious analytical journal Lab on a Chip. The CacoGoblet kit was employed to investigate the permeability and the metabolism of the compound in a gut-liver-organ-on-a-chip (OoC).